XML 107 R75.htm IDEA: XBRL DOCUMENT v3.10.0.1
Quarterly Financial Data (Unaudited) - Summary of Quarterly Financial Data (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2017
Sep. 30, 2017
Jun. 30, 2017
Mar. 31, 2017
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Selected Quarterly Financial Information [Abstract]                      
Revenues $ 26,837 $ 23,562 $ 21,416 $ 12,637 $ 13,077 $ 11,812 $ 8,253 $ 3,425 $ 84,452 $ 36,567 $ 19,389
Expenses 47,609 39,803 40,556 33,634 26,843 24,847 21,021 20,217 161,602 92,928 91,948
Net loss (19,219) (12,843) (16,640) (20,187) (13,091) (12,354) (12,491) (16,632) (68,889) (54,568) (71,658)
Net loss attributable to non-controlling interest (555)               (555)    
Net loss $ (18,664) $ (12,843) $ (16,640) $ (20,187) $ (13,091) $ (12,354) $ (12,491) $ (16,632) $ (68,334) $ (54,568) $ (71,658)
Basic and diluted net loss per share attributable to Sangamo Therapeutics, Inc. stockholders $ (0.18) $ (0.13) $ (0.17) $ (0.23) $ (0.15) $ (0.15) $ (0.17) $ (0.23) $ (0.70) $ (0.70) $ (1.02)